Fig. 2: Survival analyses of progression to dementia.
Kaplan–Meier survival analyses of progression to dementia (n = 1107). A Beta-blocker users and non-users. B Beta-agonist users and non-users.
Fig. 2: Survival analyses of progression to dementia. | npj Parkinson's Disease
